Consensus Merit Medical Systems, Inc.

Equities

MMSI

US5898891040

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
75.75 USD +0.38% Intraday chart for Merit Medical Systems, Inc. +3.67% -0.28%

Evolution of the average Target Price on Merit Medical Systems, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7d2623b.Blux_7Ym-jTXYUHdCLv1LcD6k5iMi9qi79AEkBwN6LU.Vz_0kuFpvXzlABmzYeSyWPPLwsr86ZzvirRy6mpPjv58FdWS4ECTRJwZBA~e3dfccad45b19656a7af6fdd200fb395
Needham Ups Price Target on Merit Medical Systems to $88 From $81, Maintains Buy Rating MT
Barrington Ups Price Target on Merit Medical Systems to $98 From $96, Maintains Outperform Rating MT
Oppenheimer Raises Merit Medical Systems Price Target to $87 From $82, Maintains Outperform Rating MT
Raymond James Adjusts Price Target on Merit Medical Systems to $89 From $84, Keeps Outperform Rating MT
Piper Sandler Raises Price Target on Merit Medical Systems to $95 From $88, Keeps Overweight Rating MT
Canaccord Genuity Upgrades Merit Medical Systems to Buy From Hold, Adjusts Price Target to $100 From $76 MT
Needham Lowers Price Target on Merit Medical Systems to $81 From $96, Maintains Buy Rating MT
Barrington Raises Price Target on Merit Medical Systems to $96 From $95, Reports Strong Q3 Results, Keeps Outperform Rating MT
Piper Sandler Raises Merit Medical Systems' Price Target to $92 From $85, Overweight Rating Kept MT
Barrington Raises Price Target on Merit Medical Systems to $95 From $90 Amid Acquisition of Assets From AngioDynamics and Bluegrass Vascular, Reiterates Outperform Rating MT
Needham Adjusts Price Target on Merit Medical Systems to $96 From $90, Keeps Buy Rating MT
Raymond James Adjusts Price Target on Merit Medical Systems to $93 From $88, Maintains Outperform Rating MT
Piper Sandler Raises Merit Medical Systems' Price Target to $85 From $77, Maintains Overweight Rating MT
Wells Fargo Adjusts Price Target on Merit Medical Systems to $81 From $74, Maintains Equal-Weight Rating MT
Raymond James Adjusts Price Target on Merit Medical Systems to $88 From $86, Maintains Outperform Rating MT
Needham Adjusts Price Target on Merit Medical Systems to $90 From $84, Reiterates Buy Rating MT
Barrington Ups Price Target on Merit Medical Systems to $90 From $78, Reiterates Outperform Rating MT
Raymond James Adjusts Price Target on Merit Medical Systems to $86 From $80, Maintains Outperform Rating MT
Piper Sandler Adjusts Price Target on Merit Medical Systems to $77 From $73, Maintains Overweight Rating MT
Raymond James Adjusts Price Target on Merit Medical Systems to $80 From $72, Maintains Outperform Rating MT
Needham Adjusts Price Target on Merit Medical Systems to $78 From $73, Keeps Buy Rating MT
Canaccord Genuity Downgrades Merit Medical to Hold From Buy, Price Target is $72 MT
Raymond James Adjusts Price Target on Merit Medical Systems to $72 From $71, Maintains Outperform Rating MT
Canaccord Genuity Lowers Merit Medical Systems' Price Target to $63 From $69, Buy Rating Kept MT
Canaccord Genuity Adjusts Price Target on Merit Medical Systems to $69 From $67, Reiterates Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
75.75 USD
Average target price
94.22 USD
Spread / Average Target
+24.39%
High Price Target
112 USD
Spread / Highest target
+47.85%
Low Price Target
85 USD
Spread / Lowest Target
+12.21%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Merit Medical Systems, Inc.

Needham & Co.
Oppenheimer
Barrington Research
Raymond James
Piper Sandler
Canaccord Genuity
Wells Fargo Securities
Sidoti & Co.
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings